NY-ESO-1-specific T cell receptor-engineered T cells and Tranilast, a TRPV2 antagonist bivalent treatment enhances the killing of esophageal cancer: a dual-targeted …
OB Amissah, W Chen, J de Dieu Habimana… - Cancer Cell …, 2024 - Springer
Background Esophageal cancer (EC) is a global canker notorious for causing high mortality
due to its relentless incidence rate, convoluted with unyielding recurrence and metastasis …
due to its relentless incidence rate, convoluted with unyielding recurrence and metastasis …